1 Min Read
Jan 29 (Reuters) - Lee’s Pharmaceutical Holdings Ltd :
* CHINA FDA GRANTS UNIT APPROVAL FOR CLINICAL TRIALS FOR ITS RECOMBINANT HUMAN ANTI-PD-L1 MONOCLONAL ANTIBODY INJECTION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.